Xultophy is a widely acclaimed medication brand developed by Novo Nordisk, specializing in diabetes management. It is specifically known for its injectable prescription medicine, Xultophy 100/3.6. This product is a combination of insulin degludec, a long-acting insulin, and liraglutide, a glucagon-like peptide-1 receptor agonist. It is used with diet and exercise to improve blood sugar control in adults suffering from type 2 diabetes. Xultophy is renowned for reducing both fasting and postprandial glucose, contributing to effective glycemic control. It is designed for once-daily dosing and is not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Side effects can include nausea, diarrhea, and vomiting, among others, and users should always consult medical professionals for complete information. You can conveniently purchase Xultophy from Canadian Insulin, an established online platform offering various diabetes medications. Canadian Insulin sources high-quality diabetes supplies and ensures their products are cost-effective, aiming to make diabetes management more accessible for everyone. In addition, Canadian Insulin boasts an easy ordering process, ensuring a hassle-free experience when purchasing Xultophy.